Related Experiment Video

Updated: Dec 11, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.0K

Advances in oncolytic viral therapy

Yanghee Woo1, Prasad S Adusumilli, Yuman Fong

  • 1Memorial Sloan-Kettering Cancer Center, Department of Surgery, 1275 York Avenue, New York, NY 10021, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|June 21, 2006
PubMed

Insights

Oncolytic virus therapy uses viruses to selectively kill cancer cells, offering a promising new anticancer strategy. Research focuses on enhancing efficacy and safety for treating advanced solid tumors.

Area of Science:

  • Oncology
  • Virology
  • Biotechnology

Background:

  • Oncolytic virus therapy is an emerging anticancer strategy.
  • Viruses are utilized for their natural ability to kill tumor cells directly.
  • Preclinical studies highlight the complex interplay between viruses, tumors, and hosts.

Purpose of the Study:

  • To review the theory, accomplishments, and future research directions in oncolytic virus therapy.
  • To focus on clinical trials involving oncolytic viruses as antineoplastic therapies.
  • To discuss strategies for maximizing oncolytic viral efficacy and safety.

Main Methods:

  • Review of preclinical and clinical studies on oncolytic viruses.
  • Analysis of genetic engineering and tumor biology in designing novel oncolytic viruses.
  • Summary of host-virus interactions and targeting strategies.

Main Results:

  • Novel viruses are engineered to selectively target, replicate in, and destroy cancer cells.
  • Oncolytic viruses show potential as powerful anticancer agents, particularly for advanced solid tumors.
  • Ongoing clinical trials are evaluating the efficacy and safety of these therapies.

Conclusions:

  • Oncolytic virus therapy represents a significant advancement in cancer treatment.
  • Further research and clinical trials are crucial for realizing the full potential of this approach.
  • Genetic engineering and a deeper understanding of tumor biology are key to developing effective oncolytic viruses.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.4K
Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.0K

Related Concept Videos

Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
359
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
860
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K